Investigation on a Dynamic Cohort of Italian Patients With Active ITP
ITP0918
ITALIAN ADULT IMMUNE THROMBOCYTOPENIA (ITP) REGISTRY Investigation on a Dynamic Cohort of Italian Patients With Active ITP
1 other identifier
observational
861
1 country
26
Brief Summary
The objective of the study is to produce a dynamic picture of the adult ITP natural history and management in Italy by collecting standardized information retrospective and prospective data of patients in active management through a nation-wide registry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Longer than P75 for all trials
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2018
CompletedFirst Posted
Study publicly available on registry
March 14, 2018
CompletedStudy Start
First participant enrolled
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedJuly 20, 2022
July 1, 2022
4.7 years
March 8, 2018
July 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of adverse events in ITP adult patients
After 36 months from study enrollment
Study Arms (1)
ITP patients
On active treatment
Interventions
Eligibility Criteria
All consecutive adult patients (18 years or older) in active treatment for ITP meeting one of the three conditions at their first visit after the enrolment has been opened. In all cases, patients should be enrolled at the first visit during the enrolment period (or at latest within 1 month with data referred back to the first visit).
You may qualify if:
- Patients never treated before for whom an ITP treatment is initiated for the first time by the recruiting center
- Patients already treated for whom a new line of ITP treatment is initiated by the recruiting center (the patients could have been treated elsewhere before)
- Patients who, under any ITP treatment at the recruiting center.
You may not qualify if:
- Undefined
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
Sc Ematologia E Centro Trapianti Midollo Osseo
Parma, SC, Italy
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica
Ancona, Italy
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto
Bari, Italy
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia
Bologna, Italy
Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo
Cagliari, Italy
Ctc U.O Di Ematologia Con Trapianto Di Midollo Osseo - Catania
Capranica, Italy
Arnas Garibaldi, Po Garibaldi-Nesima - Catania - Uoc Ematologia
Catania, Italy
Aou Careggi - Firenze - Sod Ematologia
Florence, Italy
Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia
Milan, Italy
Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora
Milan, Italy
Asst Di Monza, Ospedale S. Eugenio - Uo Ematologia E Cta
Monza, Italy
Ao Di Rilievo Nazionale Antonio Cardarelli - Napoli - Uoc Ematologia Con Trapianto Di Midollo
Napoli, Italy
Aou Federico Ii - Napoli - Uoc Ematologia
Napoli, Italy
Aou Maggiore Della Carita' Di Novara - Scdu Ematologia
Novara, Italy
Aou Policlinico P. Giaccone - Palermo - Uo Ematologia
Palermo, Italy
Ospedale S.M. della Misericordia - STROKE UNIT
Perugia, Italy
Asl Di Piacenza, Ospedale "Guglielmo Da Saliceto" - Ematologia E Centro Trapianti
Piacenza, Italy
Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia
Reggio Emilia, Italy
Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica
Roma, Italy
Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia
San Giovanni Rotondo, Italy
Asl Taranto, Ospedale Ss. Annunziata - Uoc Ematologia
Taranto, Italy
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino
Torino, Italy
Ente Ecclesiastico Cardinale G. Panico - Tricase - Uo Ematologia
Tricase, Italy
Azienda Sanitaria Universitaria Integrata Di Trieste - Sc Ematologia
Trieste, Italy
Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica
Udine, Italy
Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia
Vicenza, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Francesco Rodeghiero
Department of Hematology, S. Bortolo Hospital of Vicenza
- STUDY DIRECTOR
Marco Ruggeri
Department of Hematology, S. Bortolo Hospital, Vicenza
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2018
First Posted
March 14, 2018
Study Start
October 15, 2018
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
July 20, 2022
Record last verified: 2022-07